March 2023 • PharmaTimes Magazine • 4-5

Contents

Features

As the NHS remains in intensive care, its future is in doubt

We must look after an entire nation’s health – regardless of wealth

How can we use precision medicine to improve heart failure care?

Epilepsy and mental health – a patient’s perspective on breaking out

England’s prescribing trends provide a host of intriguing insights

Analysis

Pharmacy’s role in women’s health must reflect a modern approach

How can AI drive new developments in precision medicine?

The conundrum of lab plastics is making us go round in circles

Data quality governance – dispelling five common myths

Digging deep into the maelstrom of intellectual property

SmartPeople

13.
Shining lights
The pivotal and enlightening journey to conscious inclusion

17.
Dimensions of difference
Laying the foundations in order to achieve health equity

32.
We all stand together
PharmaTimes Editor talks to AstraZeneca’s Anna-Lena Engwall

34.
Difficult conversation
The NHS has been likened to an elderly patient in poor health

36.
Your moves
Where you are going and why you're going there

38.
Thinking outside the box
Mastering the art of compliant distribution in pharma

Logo

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com
https://pharmatimes.com/
Privacy Policy
Terms of Service

Categories

Explore our inspiring content by topic

PharmaTimes
News
Features
Analysis
SmartPeople

Social Footprints

Follow us on our Social Media Channels

X
linkedin